Abbreviations used in this paper: CFP, cyan fluorescent protein; FRET, fluorescence resonance energy transfer; YFP, yellow fluorescent protein.

INTRODUCTION
============

Large-conductance voltage- and Ca^2+^-activated K^+^ channels (BK channels) are modulated synergistically by voltage and Ca^2+^ ([@bib12]), providing a unique link between chemical and electrical signaling in the cell ([@bib29]). BK channels are found in a wide range of tissues, where they play diverse roles. They contribute to the feedback control of Ca^2+^ influx and neurotransmission, the repolarization of action potentials and the frequency adaptation processes in the nervous system ([@bib5]; [@bib13]), and to the tuning of the electrical resonance in hair cells ([@bib24]).

BK channels are formed as tetramers of the pore-forming α subunits that sometimes form a complex with regulatory β subunits ([@bib30]). The α subunits are coded by the *slo* gene. Cloning the cDNA that encodes the slo α subunit revealed that the predicted protein has six transmembrane regions (S1--S6), placing it in the superfamily of voltage-gated ion channels. Nevertheless, slo differs from the K~v~ family in having an additional transmembrane domain (S0) at the NH~2~ terminus, and a large COOH terminus with four hydrophobic regions originally designated S7--S10 ([@bib4]; [@bib17]). Subsequent studies have proposed the existence of several functional domains in the COOH terminus.

[@bib15] described a new class of domains present in some K^+^ channels, named RCK domains for their possible role in the regulation of the conductance to K^+^. In the bacterial MthK channel tetramer, eight RCK domains have been proposed to form a "gating ring" that transduces Ca^2+^ binding into opening of the channel pore ([@bib14]). BK α subunits present two RCK domains in the COOH-terminal region ([@bib14]; [@bib23]), separated by a nonconserved linker ([@bib25]). It is tempting to conclude that a similar gating ring mechanism is applicable in BK channels, but the differences between MthK and BK channels are substantial: the Ca^2+^ binding sites in MthK are not conserved in BK channels; MthK has a relatively low Ca^2+^ sensitivity; and the regulation mechanism of BK channels is more complex, involving both Ca^2+^ and voltage ([@bib12]). Meanwhile, some authors have proposed a role of the first RCK domain in slo tetramerization ([@bib20]).

Immediately following the second RCK domain there is a highly conserved 28--amino acid region rich in aspartate residues referred to as the "Ca^2+^ bowl" ([@bib32]). Mutations in this region have large effects on the Ca^2+^ sensitivity of slo channels ([@bib32]; [@bib25]; [@bib26]; [@bib1]), although other sites in the RCK1 domain appear to also participate in high affinity Ca^2+^ sensitivity ([@bib1]; [@bib33]) as well as in low affinity Ca^2+^ and Mg^2+^ sensitivity ([@bib28]; [@bib36]; [@bib33]).

A sequence near the COOH terminus is similar to that of the superfamily of serine proteinase (Ser-P) enzymes ([@bib18]; [@bib9]). The functional relevance of this domain is not clear. It has been demonstrated that Ser-P inhibitors bind to slo channels producing discrete subconductance events ([@bib18]; [@bib8]; [@bib9]), suggesting a role of this domain in slo gating as well as modulation by other cytoplasmic or membrane-associated regulatory components ([@bib18]).

The yellow and cyan variants of the green fluorescent protein (YFP and CFP respectively) constitute an excellent pair for fluorescence resonance energy transfer (FRET), and can be used to study the conformational rearrangements of ion channels that are associated with function ([@bib37]). The engineering of suitable GFP fusion proteins is however difficult. GFP insertion sites must be found that fulfill two requirements: (1) the fusion proteins should generate functional channels with properties similar to the wild-type channel; (2) the insertion sites should lie in appropriate locations of domains involved in the conformational rearrangements. Attempts to predict such sites have been unsuccessful, even in cases where the native protein structure is known. Given these uncertainties and the time-consuming process of generating individual fusion proteins using conventional molecular biology techniques, we decided to use transposable elements to randomly insert YFP and CFP into different domains of the human slo α-subunit (hslo). We have expressed these mutants in mammalian cells and studied their ability to form functional BK channels. Out of 55 constructs tested, 19 were expressed at the plasma membrane and form functional channels. Most of them appear to be comparable to wild-type channels in terms of voltage and Ca^2+^ sensitivity. Only two constructs with insertions within the Ca^2+^ bowl and a construct with an insertion in the RCK2 domain showed altered functional properties. Therefore, we have been able to generate rapidly a library of fluorescent hslo fusion proteins that promises to be a useful tool for future FRET studies of conformational changes of BK channels associated with function.

MATERIALS AND METHODS
=====================

Target Plasmids, Transposons, and Transposition Reactions
---------------------------------------------------------

The full-length human slo cDNA isolated from uterine smooth muscle (hslo; GenBank/EMBL/DDBJ accession no. [U11058](U11058); [@bib30]) was modified by Dr. A. Tinker in the 5′ end to carry a six-histidine tag followed by the FLAG epitope DYKDDDDK. This construct was provided to us by G. Moss (University College London, London, UK). A HindIII/NotI fragment carrying this modified hslo cDNA was cloned into a pCMVSport/βgal-derived vector. The CFP transposon \<TcPT-1\> was as previously reported ([@bib27]). The transposon encoding YFP \<TvPT-0\> was made by replacing the AscI-flanked EGFP fragment in \<TgPT-0\> ([@bib27]) with the corresponding YFP fragment (Venus variant; [@bib19]). The two transposons use different reading frames to increase the chance of insertions yielding functional proteins ([@bib27]). In view of the low probability of transposition in an in vitro reaction, a selectable marker was introduced into each transposon in the form of a Kanamicin resistance cassette (Kan^r^) flanked by SrfI restriction sites. Immediately before the Kan^r^ there is a stop codon; therefore, each clone containing an in-frame insertion should encode a truncated protein with YFP or CFP at the COOH terminus.

The transposon can be inserted anywhere in the target plasmid; in our case, the probability that the insertion occurs into the hslo cDNA, in the correct orientation and reading frame, is expected to be ∼9%. Thus our screening strategy consisted of several steps. First, we performed two separate in vitro transposition reactions, one for each transposon, following the protocol described by [@bib27]. The resulting DNA was transformed into *Escherichia coli*. Single colonies resistant to ampicillin (transformed clones) and kanamycin (marker for transposition) were picked and grown in 96-well plates. Transposed plasmids were then isolated in a 96-well format with Eppendorf PerfectPREP-96 Vac Direct Bind miniprep kits (Eppendorf) on a PerkinElmer MultiPROBE II HT liquid handling robot. Approximately 10,000 transposed clones were obtained; we purified DNA from 672 clones of each reaction (1,344 clones in total). We identified correctly oriented in-frame insertions by transiently transfecting each truncated construct into HEK293 cells, which were screened for fluorescence. The probability of transposition is not uniform ([@bib10]), so we expected some clones to have identical insertion sites. The 5′ boundaries of the insertions were determined for all fluorescent clones by DNA sequencing (HHMI Biopolymer/Keck Foundation Biotechnology Laboratory, Yale University School of Medicine) to identify unique insertions and localize the exact insertion site. These clones were digested with SrfI to remove the Kan^r^ cassette and obtain the full-length fusion constructs.

Screening of Transposed Clones
------------------------------

HEK-293 cells were seeded in 96-well glass bottom tissue culture plates (NalgeNUNC) and grown in DMEM (GIBCO BRL) supplemented with 10% FBS at 37°C in an atmosphere containing 5% CO~2~. Cells were transfected with plasmid DNA from individual CFP- and YFP-transposed clones and Lipofectamine 2000 (GIBCO BRL) following standard protocols. The cells were screened for YFP and CFP fluorescence ∼24 h after transfection with a 20× objective on a Carl Zeiss MicroImaging, Inc. inverted fluorescence microscope.

Cell-surface Immunostaining
---------------------------

CHO cells were plated in Falcon culture slides (Becton Dickinson Labware) and grown in α-MEM (GIBCO BRL) with 10% FBS at 37°C in 5% CO~2~. Cells were transfected 18--24 h before experiments with plasmid DNA of each full-length fusion protein and Lipofectamine 2000 (GIBCO BRL). All staining procedures were performed at 4°C. Cells were washed twice with PBS^2+^ (PBS with 2 mM CaCl~2~ and 0.5 mM MgCl~2~), blocked with 1% BSA and 10% goat serum for 1 h and further incubated with 5 μg/ml mouse monoclonal anti-FLAG M2 antibody (Sigma-Aldrich) for 45 min. Cells were then fixed with 2% formaldehyde in PBS^2+^ for 10 min, washed extensively with PBS and incubated with 10 μg/ml of an Alexa Fluor 594--conjugated goat anti--mouse IgG antibody (Molecular Probes) for 45 min. After several washes with PBS, the cells were mounted with Aquamount (Lerner Laboratories). Images of the slides were collected with a Carl Zeiss MicroImaging, Inc. laser scanning microscope equipped with a 40× oil-immersion objective. YFP and CFP were excited using the Argon laser 488-nm line, whereas Alexa 594 was excited using the He-Ne laser 568-nm line. The emission signals were filtered with a Carl Zeiss MicroImaging, Inc. 515--565-nm filter (YFP/CFP emission) or with a 590--640 filter (Alexa 594 signal).

Triton X-100 Solubilization and Western Blot Analysis
-----------------------------------------------------

A protocol modified from [@bib35] was used. Transfected CHO cells were permeabilized in lysis buffer (150 mM NaCl, protease inhibitors, 1 μg/ml DNaseI, 20 mM Tris-HCl, pH 7.4) containing various concentrations of Triton X-100 (0, 0.1, 0.4, 1, 2%). After a 10-min incubation on ice, lysates were centrifuged for 5 min at 15,000 *g*. Solubilized fractions were set aside while insoluble fractions were washed twice with PBS and resuspended in equal volume as soluble fractions (60 μL). SDS loading buffer was added to both soluble and insoluble fractions and 30-μl aliquots were separated in 7.5% SDS-PAGE gels. We did not boil the samples, since that consistently produced aggregates of hslo α subunits that would run as high molecular weight complexes. Proteins were transferred to Immun-blot PDVF membranes (Bio-Rad Laboratories), and hslo was detected by Western blotting with 10 μg/ml anti-FLAG monoclonal antibodies (Sigma-Aldrich). Anti--mouse IgG secondary antibodies conjugated to peroxidase (Sigma-Aldrich) were used at 1:10,000 dilution and the signal was developed with the ECL+ system (Amersham Pharmacia Biotech).

Electrophysiological Recordings
-------------------------------

CHO cells were grown on 12-mm glass coverslips (Fisherbrand) in α-MEM (GIBCO BRL) with 10% FBS and transfected with plasmid DNA and Lipofectamine 2000 (GIBCO BRL). 18--24 h after transfection, fluorescent cells expressing hslo-YFP or hslo-CFP were assayed for hslo function. Recordings were done in the cell-attached or inside-out patch clamp configurations ([@bib11]) at 22--24°C. Patch pipettes were made of borosilicate glass (Kimax) and had resistances of 1--3 MΩ. Data were acquired using an EPC-9 amplifier and Pulse acquisition software (HEKA Electronik). Records were digitized at 50-μs intervals. Capacitance and leak currents were subtracted using a *P*/5 leak subtraction protocol. Conductance--voltage (*G-V*) curves were obtained by measuring the amplitude of tail currents 500 μs after repolarization to −70 mV from the various test voltages. Current levels were highly variable between patches; however, for all functional constructs, the maximal currents at 120 mV were consistently in the range of 500 pA to 5 nA, ∼60% the amplitude obtained with wild-type hslo channels. Currents obtained at all concentrations within a patch were normalized to the maximum peak current at 100 μM Ca^2+^ and *G-V* curves were fitted to a Boltzmann function using Igor Pro software (Wavemetrics Inc.). Values in the text are given as mean ± SEM.

Recording solutions contained (in mM): pipette, 80 KMeSO~3~, 60 *N*-methylglucamine-MeSO~3~, 20 HEPES, 2 KCl, 2 MgCl~2~ (pH 7.4); bath solution, 80 KMeSO~3~, 60 *N*-methylglucamine-MeSO~3~, 20 HEPES, 2 KCl, 1 HEDTA, and CaCl~2~ to give the appropriate free Ca^2+^ concentration (pH 7.4). No Ca^2+^ chelator was used in solutions containing 100 μM free Ca^2+^ or higher. To prevent Ba^2+^ block at high voltages ([@bib6]), 50 μM (+)-18-crown-6-tetracarboxylic acid (18C6TA) was added to all bath solutions. The amount of total CaCl~2~ needed to obtain the desired free Ca^2+^ concentration was calculated using the program Max Chelator ([@bib2]), which was downloaded from [www.stanford.edu/\~patton/maxc.html](http://www.stanford.edu/~patton/maxc.html). Free Ca^2+^ was measured with a Ca^2+^-sensitive electrode (Orion electrode, Thermo Labsystems). Solutions were exchanged using the DAD-VC superfusion system from ALA Scientific Instruments.

RESULTS AND DISCUSSION
======================

Our aim was to generate a library of fluorescent functional hslo constructs as a tool for future use in spectroscopic studies of BK channel conformational rearrangements during gating. Obtaining a large number of constructs in a short period of time was possible by randomly inserting fluorescent protein domains into various sites in the hslo sequence. To this end, we used a newly developed technique based on a modified Tn5 transposon ([@bib22]) that carries the sequence of either the yellow fluorescent protein (YFP) or the cyan fluorescent protein (CFP; [@bib27]). Transposons consist of any sequence delimited by the mosaic ends (MEs), which are two 19--base pair repeats. In an in vitro reaction, a recombinant Tn5 transposase binds these MEs and catalyzes the random insertion of the transposon into the plasmid carrying the hslo sequence. We created two different transposons, \<TvPT-0\> and \<TcPT-1\>. When these transposons are inserted into the sequence, in the correct orientation and reading frame, they produce a fluorescent fusion protein.

We transfected an initial set of 1,344 YFP and CFP insertion clones into HEK293 cells and screened for fluorescence (see MATERIALS AND METHODS). In our system a random transposition would be expected to result in an in-frame, correctly oriented insertion into the hslo coding region with a probability of 9%. Indeed, from the 1,344 random insertion clones, we obtained 101 constructs that produced fluorescent fusion protein (61 YFP and 40 CFP fluorescent insertions). Thus, consistent with earlier studies ([@bib27]), it appears that nearly all fusion constructs yield correctly folded GFP domains. To verify that the sequence of the fluorescent proteins had been inserted into unique sites in the hslo sequence, the constructs were digested with restriction enzymes AscI (whose site flanks the YFP or CFP sequence in the transposons) and EcoRI (a unique site in the hslo sequence). The resulting gels revealed a common band (728 base pairs) in every lane, corresponding to the YFP or CFP insert, and two more bands of different sizes in concordance with the different sites of insertion of the transposons. A representative gel is shown in [Fig. 1](#fig1){ref-type="fig"} A. Sequencing the 101 clones revealed 55 unique insertions (33 YFP and 22 CFP; [Fig. 1](#fig1){ref-type="fig"} and [Table I](#tbl1){ref-type="table"}). These 55 clones were digested with SrfI and religated to remove the Kan^r^ gene and stop codon (see MATERIALS AND METHODS), yielding the full-length constructs. All of the initial clones were still fluorescent as full-length constructs. All constructs showed similar high levels of expression in HEK293 cells, with a large proportion of perinuclear YFP or CFP fluorescence consistent with localization to the ER, probably due to overexpression of the proteins ([Fig. 1](#fig1){ref-type="fig"} B).

![55 fluorescent fusion hslo proteins were obtained with unique insertion sites. (A) AscI/EcoRI digestion was used to test the various hslo-YFP/CFP fusion constructs. Lane 1, 1 kb ladder DNA marker; lanes 2--6, representative hslo-YFP fusion proteins; lanes 7--11, representative hslo-CFP fusions. Note the common band (F) of 728 base pairs in every lane corresponding to CFP or YFP. The other two bands (H1, H2) show different sizes for each construct, depending on the site in which the transposon has been inserted. (B) Cell expression of fluorescent hslo-CFP or -YFP fusion proteins. Left panel, construct 829 (CFP); middle and right panels, constructs 1062 and 471, respectively (YFP). HEK293 cells were transiently transfected with the fusion constructs and imaged for fluorescence after 24 h. (C) Successful insertions of YFP or CFP into the different regions of the hslo α subunit. White circles, YFP; gray circles, CFP. Approximate insertion sites are shown. Refer to [Table I](#tbl1){ref-type="table"} for the exact position in the hslo sequence where the insertion occurred.](200509368f1){#fig1}
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Determined with surface immunostaining. Y, very clear surface labeling; N, no surface labeling; L, very low surface labeling, probably not expressed at the plasma membrane.
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Statistically significant changes (P \< 0.01) when compared with wild type.

Inspection of [Fig. 1](#fig1){ref-type="fig"} C and [Table I](#tbl1){ref-type="table"} shows that even though insertions were obtained over most of the coding sequence, a majority of them cover the COOH-terminal domain, with fewer insertions in the transmembrane domain. This apparent nonrandom distribution can be explained by two reasons. First, the Tn5 transposon behavior is not completely sequence independent ([@bib10]). Second, and more importantly, if the insertion results on an aberrant protein that is improperly folded and consequently removed by cell degradation systems, it will not be recovered as a positive insertion in our screening process, which is based on cell expression of COOH-terminal fusions of the fluorescent protein. We speculate that many insertions in the transmembrane domain may result in fusion proteins that are degraded by the cell. Nevertheless, we recovered 55 insertions of the fluorescent proteins that cover all regions of interest ([Fig. 1](#fig1){ref-type="fig"} C and [Table I](#tbl1){ref-type="table"}). Seven constructs were obtained with insertions between the NH~2~ terminus and the start of the RCK1 domain, including three in helices 3 and 6 and four in loops or regions at the end of the helices; 12 constructs had insertions in the RCK1 domain; three constructs hold insertions in the linker between RCK domains; 13 constructs in the RCK2 domain; two of them showed insertions in the Ca^2+^-bowl domain; finally, 15 of the constructs had insertions in the Ser-P--like domain, whereas the remaining three construct insertions were in the COOH terminus of the hslo sequence.

The complete sequence of a representative insertion is shown in [Fig. 2](#fig2){ref-type="fig"}. It should be kept in mind that the transposition process involves a duplication of the nine base pairs flanking the transposon insertion site ([Fig. 2](#fig2){ref-type="fig"}; see also [@bib27]; [@bib21]). This generates a duplication of three amino acids of the hslo sequence in addition to the linker flanking the fluorescent protein ([@bib27]). We identify the site of an insertion by the number of the residue preceding the duplicated triplet, using the native hslo numbering (GenBank/EMBL/DDBJ accession no. [U11058](U11058)).

![Insertion of the transposon involves a 9-bp duplication of the sequence flanking the insertion site. The insertion 904 in the Ca^2+^ bowl is shown as an example. (A) Position of the Ca^2+^ bowl in the general topology of the hslo channel. An arrow indicates the site of insertion of the YFP transposon, between amino acids 904 and 905. (B) Detailed cDNA sequence (top rows) and amino acid sequence (bottom rows) of the Ca^2+^ bowl region after in-frame insertion of the transposon. Different parts of the nucleotide sequence are color coded: red, Ca^2+^ bowl; black, mosaic ends (ME); gray, linker and AscI sites; green, YFP. Nine base pairs of the channel sequence flanking the insertion site are duplicated after transposon insertion. Therefore, three amino acids are duplicated, marked with blue boxes in the figure.](200509368f2){#fig2}

We next sought to determine which of the 55 unique constructs were able to form functional channels at the plasma membrane. All constructs showed high levels of fluorescence, but much of the protein was localized intracellularly ([Fig. 1](#fig1){ref-type="fig"} B). Therefore, it was difficult to determine whether any of the hslo fluorescent protein was at the plasma membrane. Since screening of all 55 constructs by patch-clamp would have been time consuming, we developed an immunoassay to detected hslo protein surface expression. Because the NH~2~ terminus of the hslo channel is exoplasmic ([@bib31]), and our constructs had a FLAG epitope at the NH~2~ terminus, we were able to test plasma membrane expression of the 55 constructs of the library by surface immunostaining. For these experiments, and for functional analysis of hslo fusion proteins, we used CHO cells because they do not have endogenous potassium channels ([@bib34]). Cells were transiently transfected with the fusion constructs, and protein expressed at the plasma membrane was immunolabeled with anti-FLAG primary antibody and a secondary antibody conjugated to a red fluorophore (Alexa 594). To ensure that the immunodetected channels were exclusively at the extracellular membrane, primary antibody was added before fixation of nonpermeabilized cells and all experiments were performed at 4°C to avoid membrane internalization processes. Secondary antibody was then added to the cells as described in MATERIALS AND METHODS. As shown in [Fig. 3](#fig3){ref-type="fig"} A, nontransposed wild-type hslo channels showed strong surface expression. All 55 constructs of the library showed YFP or CFP fluorescence in the cell, but only 19 of them showed clear membrane expression. The approximate location of the 19 insertions that are expressed at the plasma membrane is shown in [Fig. 3](#fig3){ref-type="fig"} B (for the exact location of insertions, refer to [Table I](#tbl1){ref-type="table"}). All insertions in the linker, and most of insertions in the second half of the RCK2 domain, calcium bowl, Ser-P domain, and COOH terminus showed strong plasma membrane expression. None of the insertions obtained in the NH~2~ terminus, transmembrane helices, RCK1 domain, or the first half of the RCK2 domain were expressed at the surface.

![Expression of fluorescent hslo fusion proteins in the plasma membrane. (A) Confocal images of CHO cells expressing different hslo constructs. Transiently transfected hslo-YFP or CFP fusion proteins were inmunolabeled in live CHO cells before fixation. Left column, YFP fluorescence; middle column, surface immunofluorescence of hslo with Alexa 594--conjugated secondary antibody; far right, merged image. Top panels correspond to hslo channels before the transposition process. Middle and bottom panels show results obtained with two representative YFP-hslo constructs (1062-YFP in the COOH terminus and 471-YFP in the RCK1 domain). (B) 19 out of the 55 fluorescent hslo fusion proteins showed clear plasma membrane expression (red arrows). Yellow circles, YFP; blue circles, CFP. Approximate insertion sites are shown. Refer to [Table I](#tbl1){ref-type="table"} for the exact position in the hslo sequence where each insertion occurred.](200509368f3){#fig3}

The highest density of membrane-expressed insertions was found at the Ser-P domain. Nevertheless, 8 constructs out of 15 were retained intracellularly. A possible reason for this could be that some insertions are disrupting secondary structural elements (α helices or β strands) in the Ser-P domain. However, when the insertions are mapped onto the secondary structure, no obvious pattern emerges (unpublished data). A similar analysis was performed with insertions in the RCK domains, which also show an α/β protein structure, but again no obvious pattern is seen. These results are reminiscent of those of [@bib27], who transposed the G-protein subunit α~s~ and surprisingly obtained the most functional fusion protein with the insertion of GFP into the middle of an α-helix. The hslo COOH-terminal region tolerated two insertions out of three. This is in concordance with results by other authors, who observed that deleting the last segment of hslo leads to functional channels very similar to wild type ([@bib20]).

We then tested the function of the 19 constructs expressed at the plasma membrane. Electrophysiological properties of the fluorescent hslo fusion proteins were investigated in transiently transfected CHO cells and compared with wild-type BK channels transfected into the same cell line. A low level of single channel activity was detected in cell-attached patches. When a patch was excised to a medium containing 100 μM Ca^2+^, macroscopic K^+^ currents were observed ([Fig. 4, A and B](#fig4){ref-type="fig"}). Typically, we observed high current levels in patches obtained from all 19 constructs. These currents were Ca^2+^- and voltage-dependent ([Fig. 4, C and D](#fig4){ref-type="fig"}). Insertion of the fluorescent proteins did not change significantly the conductance of the channel, which was ∼215 pS for the wild type and varied from 175 to 238 pS for the various fluorescent mutants, probably due to the intrinsic variability of single channels.

![Electrophysiologi-cal properties of hslo fluorescent fusion proteins. (A) Hslo currents were recorded with depolarizing pulses to +60 mV from a holding potential of −70 mV. Single channel recordings of wild-type hslo (top traces) and a representative hslo-YFP construct (1062-YFP; bottom) obtained in cell-attached patches at +60 mV. The arrows indicate the closed current level. (B) The same patches shown in A were excised to a medium containing 100 μM Ca^2+^. Currents are shown from 100-ms depolarizations from −70 mV to +60 mV. (C) Representative current families recorded from CHO inside-out patches in 100 μM Ca^2+^, from a holding potential of −70 mV. WT and 1062-YFP currents are shown at voltages between −70 and +120 mV in steps of 10 mV, whereas 901-CFP currents were obtained at +10 to +200 mV. (D) Normalized *G-V* curves are shown from wild-type hslo (WT, no insertions: black curve and symbols) and seven representative insertions. Each set of points was fitted to a Boltzmann function. Error bars represent SEM with *n* values as listed in [Table I](#tbl1){ref-type="table"}.](200509368f4){#fig4}

It is remarkable that despite the insertion of a large fluorescent domain in the channel protein, 16 out of 19 membrane-expressed fusion proteins showed *G-V* curves very similar to that of the wild-type hslo channel ([Fig. 4](#fig4){ref-type="fig"} D and [Table I](#tbl1){ref-type="table"}). Variations on the order of 20 mV in the half-activation voltage values (*V* ~1/2~) between different patches were observed, consistent with findings by other authors ([@bib12]), and possibly due to differences in the redox state of channels ([@bib7]). The two insertions in the calcium bowl (901-CFP and 904-YFP) showed a strong shift in the *G-V* curve at 100 μM Ca^2+^, ∼100 mV in the depolarizing direction ([Fig. 4](#fig4){ref-type="fig"} D and [Table I](#tbl1){ref-type="table"}). Interestingly, an insertion in the RCK2 domain, 829-CFP, also showed a shift in the *G-V* curve of ∼50 mV to more positive voltages.

To characterize the Ca^2+^ sensitivity of the various constructs, we studied the *G-V* relationships at Ca^2+^ concentrations between 1 μM and 100 μM. As shown in [Table I](#tbl1){ref-type="table"} and [Fig. 5](#fig5){ref-type="fig"}, *V* ~1/2~ values at the different Ca^2+^ concentrations for 16 of the 19 constructs were not significantly different from the wild-type hslo channel ([Fig. 5](#fig5){ref-type="fig"} A), indicating that the insertion of the fluorescent proteins did not affect the ability of Ca^2+^ to regulate the channel. Nevertheless, one insertion in the Ca^2+^ bowl (construct 901-CFP) reduced the ability of Ca^2+^ to shift the *G-V* curve to more negative voltages. In both this construct and 904-YFP the mutants\' curves were ∼100 mV right-shifted when compared with the corresponding wild-type curves between 1 and 100 μM Ca^2+^ (Table II; [Fig. 4](#fig4){ref-type="fig"} D; [Fig. 5, C, D, and F](#fig5){ref-type="fig"}). These results are reminiscent of findings by [@bib25] and [@bib1], who observed large effects on *G-V* curves from deletions or point mutations in the Ca-bowl region. Our results, obtained after a random mutagenesis of the hslo channel, give additional unbiased support to the conclusion that the Ca^2+^ bowl is a sensitive region for regulatory effects on the channel.

![Insertions 829, 901, and 904 show altered *G*-*V* curves. Data are shown from (A) wild type hslo, (B) an insertion in the RCK2 domain that showed little change, (C and D) insertions in the Ca bowl whose *G*-*V* curves were significantly shifted, and (E) an insertion in the RCK2 domain that also shifted the *G*-*V* curve. Ca^2+^ concentrations are as indicated in the figure. On the left are representative current families (with 100 μM Ca^2+^) used to obtain the *G-V* curves on the right. Holding potential was −70 mV. Cells were depolarized to between −70 and +120 mV (WT, 866-YFP, and 829-YFP), +10 and +200 (901-CFP), or +10 and +190 (904-YFP). All repolarizations were to −70 mV. Note the different time scale in B. (F) Half maximal activation voltage *V* ~1/2~ vs. \[Ca^2+^\] for the constructs shown in A--D. The points plotted are average parameter values determined from experiments fitted individually with a Boltzmann function. The wild-type values are connected with lines. Error bars are smaller than the symbols. (G) Apparent gating valence *z* vs. \[Ca^2+^\]. Symbols represent channel constructs as in E. Values of *V* ~1/2~ and *z* are listed in [Table II](#tbl2){ref-type="table"} TABLE IIBoltzmann Fit Parameters for Wild Type and Constructs 829, 866, 901, and 904 G-V Curves\[Ca^2+^\]Construct*V* ~1/2~*zn*mV1 μMWild type113 ± 50.99 ± 0.016866-YFP98 ± 80.98 ± 0.038901-CFP201 ± 31.11 ± 0.043904-YFP203 ± 51.05 ± 0.033829-YFP131 ± 21 ± 0.02310 μMWild type38 ± 50.95 ± 0.016866-YFP28 ± 80.94 ± 0.0210901-CFP164 ± 31.01 ± 0.0053904-YFP149 ± 21.02 ± 0.0033829-YFP79 ± 80.98 ± 0.013100 μMWild type−3 ± 40.96 ± 0.0058866-YFP−14 ± 80.95 ± 0.017901-CFP117 ± 60.97 ± 0.015904-YFP100 ± 50.97 ± 0.024829-YFP53 ± 70.98 ± 0.014[^2]. Error bars represent SEM.](200509368f5){#fig5}

When studied over the 1--100 μM Ca^2+^ range, the 829-CFP construct also showed a significant shift of the *G-V* curve (Table II; [Fig. 4](#fig4){ref-type="fig"} D; [Fig. 5, E and F](#fig5){ref-type="fig"}). The S829 residue is situated in the COOH terminus of the RCK2 domain, 54 residues away from the Ca^2+^ bowl. Interestingly, the other three insertions obtained in the RCK2 region (854-YFP, 860-CFP, and 866-YFP) showed no significant differences in the *G-V* curves with the wild type, although they are closer in the amino acid sequence to the Ca^2+^ bowl region.

Finally, we speculated that the reasons why many of the insertions were not expressed at the membrane could be one or a combination of the following: a total misfolding and aggregation of hslo subunits; a defect in protein tetramerization; or defects in channel trafficking. We used a biochemical approach to address the first possibility. The fusion proteins were expressed in CHO cells and tested for solubility in buffers containing different concentrations of the nonionic detergent Triton X-100. Insolubility in this detergent is an indicator of protein misfolding and aggregation ([@bib16]; [@bib35]). We performed these experiments with five representative constructs that are expressed at the plasma membrane (insertions 667 in the linker, 854 and 866 in the RCK2 domain, 901 in the Ca^2+^ bowl, and 1062 in the Ser-P domain) and another four representative intracellularly retained insertions (insertions 13 at the NH~2~ terminus, 336 at the end of S6, 471 in the RCK1 domain, and 780 in the RCK2). Every construct tested has a solubilization profile indistinguishable from the wild-type hslo protein (representative examples are shown in [Fig. 6](#fig6){ref-type="fig"}). A substantial part of the protein was solubilized with 0.1% of Triton X-100 and solubilization was complete with 1% of Triton X-100. This rules out the possibility that some mutant proteins are grossly misfolded and aggregated.

![Hslo fluorescent fusion proteins do not form insoluble aggregates in CHO cells. Western blot of CHO cells transfected with wild-type hslo (WT, top panel), a construct expressed at the plasma membrane, 1062-YFP (1062; second panel), a construct that is retained intracellularly, 780-YFP (780; third panel), or nontransfected cells (NT; bottom panel). Cells were permeabilized in lysis buffer containing 0%, 0.1%, 0.4%, 1%, and 2% Triton X-100 detergent. S, soluble fractions; I, insoluble fractions. For each construct, essentially all of the hslo protein is solubilized by 1% detergent. Doublet bands were sometimes seen from the fusion proteins. These were unaffected by removal of N-linked glycosylation after PNGase F pretreatment, but became single bands when higher SDS concentrations were used. Presumably they arose from incomplete unfolding of GFP domains in SDS. Hslo bands were immunodetected with anti-FLAG monoclonal antibodies. Bars to the left of the panels indicate migration of molecular mass markers (75, 100, and 150 kD).](200509368f6){#fig6}

The results presented in [Fig. 6](#fig6){ref-type="fig"} suggest that the insertion of the GFP domain in certain regions of the channel could interfere more subtly with hslo folding, causing defects that impair protein tetramerization or interfere with trafficking of the channel. [@bib20] have demonstrated the existence of several regions required for functional channel tetramerization and expression. The most important comprises the first half of the RCK1 domain, and six of our constructs present insertions in that area; none of them result in surface-expressed protein ([Table I](#tbl1){ref-type="table"}). These authors also showed that more distal domains (amino acids 500--528) could contribute to tetramerization of the channel. Two of the fluorescent fusion hslo proteins of our library contain insertions in this region and are also unable to go to the membrane ([Table I](#tbl1){ref-type="table"}).

Random insertions of GFP domains have previously been performed in three other systems, where the frequency of obtaining functional fusion proteins has been in the range of 10--20%. [@bib3] used a strategy involving random nicks to introduce the GFP sequence into the *Dictyostelium* protein kinase A regulatory subunit gene. Of the 14 full-length fusion proteins that were characterized, three showed cAMP-dependent regulatory activity. [@bib27] used transposons to create GFP fusions with the G-protein α~s~ subunit and with the glutamate receptor subunit GluR1. From 12 Gα~s~ constructs they found one with clear functional activity; out of 29 GluR1 fusion constructs they reported glutamate-activated currents in six. In view of these results, our 35% success rate (19 high-expressing ion channels out of a total of 55 hslo fusion constructs) is quite high, and illustrates a remarkable ability of the BK channel to tolerate insertions in its tail domain. The battery of functional constructs obtained here promise to be useful in future spectroscopic studies of channel conformational changes.
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